In vivo studies using mouse models showed that the absence of EGFR and its downstream signaling by genetically deleting the EGFR in tumour cells led to a significantly diminished infiltration of FoxP3 expressing Treg cells in EGFR deficient tumours in comparison to wt EGFR tumours [49]. The gene discussed is FOXP3; the disease is neoplasm.